Imaging-guided prostate biopsy: Conventional and emerging techniques

Radiographics

Volumn 32, Issue 3, 2012, Pages 819-837

  Yacoub, Joseph H ^a   Verma, Sadhna ^b   Moulton, Jonathan S ^b   Eggener, Scott ^a   Oto, Aytekin ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED SURGERY; ENDOSCOPIC ECHOGRAPHY; FORECASTING; HUMAN; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; MALE; NEEDLE BIOPSY; PROSTATE TUMOR; ROBOTICS;

BIOPSY, NEEDLE; FORECASTING; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; PROSTATIC NEOPLASMS; ROBOTICS; SURGERY, COMPUTER-ASSISTED; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 84861132425     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.323115053     Document Type: Article

References (83)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60(5):277-300.
2. Albertsen PC. The unintended burden of increased prostate cancer detection associated with prostate cancer screening and diagnosis. Urology 2010;75 (2):399-405.
3. Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28(7): 1117-1123.
4. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28(1):126-131.
5. Stattin P, Holmberg E, Johansson JE, et al. Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study. J Natl Cancer Inst 2010;102(13):950-958.
6. Berglund RK, Masterson TA, Vora KC, Eggener SE, Eastham JA, Guillonneau BD. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance. J Urol 2008;180(5):1964-1967; discussion 1967-1968.
7. Andrén O, Fall K, Franzén L, Andersson SO, Johansson JE, Rubin MA. How well does the Gleason score predict prostate cancer death? a 20-year followup of a population based cohort in Sweden. J Urol 2006;175(4):1337-1340.
8. Tamada T, Sone T, Jo Y, et al. Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade. J Magn Reson Imaging 2008;28(3): 720-726.
9. Woodfield CA, Tung GA, Grand DJ, Pezzullo JA, Machan JT, Renzulli JF 2nd. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR Am J Roentgenol 2010;194(4):W316-W322.
10. Turkbey B, Shah VP, Pang Y, et al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 2011;258(2):488-495.
11. Hambrock T, Fütterer JJ, Huisman HJ, et al. Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility. Invest Radiol 2008;43 (10):686-694.
12. Takashima R, Egawa S, Kuwao S, Baba S. Anterior distribution of Stage T1c nonpalpable tumors in radical prostatectomy specimens. Urology 2002;59 (5):692-697.
13. Franiel T, Stephan C, Erbersdobler A, et al. Areas suspicious for prostate cancer: MR-guided biopsy in patients with at least one transrectal US-guided biopsy with a negative finding-multiparametric MR imaging for detection and biopsy planning. Radiology 2011;259(1):162-172.
14. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142(1):71-74; discussion 74-75.
15. Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006;61(2):142-153.
16. Durkan GC, Sheikh N, Johnson P, Hildreth AJ, Greene DR. Improving prostate cancer detection with an extended-core transrectal ultrasonography-guided prostate biopsy protocol. BJU Int 2002;89 (1):33-39.
17. Presti JC Jr, Chang JJ, Bhargava V, Shinohara K. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 2000;163(1):163-166; discussion 166-167.
18. Bazinet M, Karakiewicz PI, Aprikian AG, et al. Value of systematic transition zone biopsies in the early detection of prostate cancer. J Urol 1996;155(2): 605-606.
19. Liu IJ, Macy M, Lai YH, Terris MK. Critical evaluation of the current indications for transition zone biopsies. Urology 2001;57(6):1117-1120.
20. Martino P, Scattoni V, Galosi AB, et al. Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiation therapy, cryotherapy, HIFU). World J Urol 2011;29(5):595-605.
21. Casciani E, Polettini E, Carmenini E, et al. Endorectal and dynamic contrast-enhanced MRI for detection of local recurrence after radical prostatectomy. AJR Am J Roentgenol 2008;190(5): 1187-1192.
22. Scattoni V, Montorsi F, Picchio M, et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int 2004;93(5):680-688.
23. Zangos S, Eichler K, Engelmann K, et al. MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol 2005;15(1):174-182.
24. Lee L, Pilcher J. The role of transrectal ultrasound and biopsy in the diagnosis and management of prostate cancer. Imaging 2008;20(2):122-130.
25. Mitterberger M, Pinggera GM, Horninger W, et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol 2007;178(2):464-468; discussion 468.
26. Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002;167(4): 1648-1652.
27. Aigner F, Pallwein L, Mitterberger M, et al. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate. BJU Int 2009;103(4):458-463.
28. König K, Scheipers U, Pesavento A, Lorenz A, Ermert H, Senge T. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol 2005;174(1):115-117.
29. Salomon G, Köllerman J, Thederan I, et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 2008;54(6):1354-1362.
30. Pallwein L, Mitterberger M, Pinggera G, et al. Sonoelastography of the prostate: comparison with systematic biopsy findings in 492 patients. Eur J Radiol 2008;65(2):304-310.
31. Kapoor A, Kapoor A, Mahajan G, Sidhu BS. Real-time elastography in the detection of prostate cancer in patients with raised PSA level. Ultrasound Med Biol 2011;37(9):1374-1381.
32. Aigner F, Pallwein L, Junker D, et al. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less. J Urol 2010;184(3):913-917.
33. Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology 2010;76(5): 1025-1033.
34. Cantwell CP, Hahn PF, Gervais DA, Mueller PR. Prostate biopsy after ano-rectal resection: value of CT-guided trans-gluteal biopsy. Eur Radiol 2008;18 (4):738-742.
35. Shinohara K, Gulati M, Koppie TM, Terris MK. Transperineal prostate biopsy after abdominoperineal resection. J Urol 2003;169(1):141-144.
36. Seaman EK, Sawczuk IS, Fatal M, Olsson CA, Shabsigh R. Transperineal prostate needle biopsy guided by transurethral ultrasound in patients without a rectum. Urology 1996;47(3):353-355.
37. D'Amico AV, Tempany CM, Cormack R, et al. Transperineal magnetic resonance image guided prostate biopsy. J Urol 2000;164(2):385-387.
38. Shen B, Angermeier KW, Remzi FH, Katz S. Screening and diagnosis of prostate cancer in patients with ileal pouch-anal anastomosis: consensus from an expert panel. Am J Gastroenterol 2011;106 (2):186-189.
39. Fergany AF, Angermeier KW. A technique of transrectal ultrasound guided transperineal random prostate biopsy in patients with ulcerative colitis and an ileal pouch. J Urol 2000;163(1):205-206.
40. Bott SR, Henderson A, Halls JE, Montgomery BS, Laing R, Langley SE. Extensive transperineal template biopsies of prostate: modified technique and results. Urology 2006;68(5):1037-1041.
41. Pinkstaff DM, Igel TC, Petrou SP, Broderick GA, Wehle MJ, Young PR. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience. Urology 2005;65(4):735-739.
42. Thompson IM, Pauler DK, Goodman PJ, et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med 2004;350(22):2239-2246.
43. Pondman KM, Fütterer JJ, ten Haken B, et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol 2008;54 (3):517-527.
44. Engelhard K, Hollenbach HP, Kiefer B, Winkel A, Goeb K, Engehausen D. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device. Eur Radiol 2006;16(6): 1237-1243.
45. Hambrock T, Somford DM, Hoeks C, et al. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. J Urol 2010;183(2):520-527.
46. Yakar D, Hambrock T, Hoeks C, Barentsz JO, Fütterer JJ. Magnetic resonance-guided biopsy of the prostate: feasibility, technique, and clinical applications. Top Magn Reson Imaging 2008;19(6): 291-295.
47. Chun FK, Steuber T, Erbersdobler A, et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 2006;49(5):820-826.
48. Lawrentschuk N, Haider MA, Daljeet N, et al. 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging. BJU Int 2010;105(9): 1231-1236.
49. Bott SRJ, Young MPA, Kellett MJ, Parkinson MC; contributors to the UCL Hospitals' Trust Radical Prostatectomy Database. Anterior prostate cancer: is it more difficult to diagnose? BJU Int 2002;89(9): 886-889.
50. Choi YJ, Kim JK, Kim N, Kim KW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. RadioGraphics 2007;27(1):63-75; discussion 75-77.
51. Beyersdorff D, Taupitz M, Winkelmann B, et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002;224(3):701-706.
52. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. II. Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59(1):61-71.
53. Mohler J, Bahnson RR, Boston B, et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw 2010;8(2):162-200.
54. Izawa JI, Klotz L, Siemens DR, et al. Prostate cancer screening: Canadian guidelines 2011. Can Urol Assoc J 2011;5(4):235-240.
55. Lawrentschuk N, Fleshner N. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int 2009;103 (6):730-733.
56. Kumar V, Jagannathan NR, Kumar R, et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml. NMR Biomed 2007;20(1):11-20.
57. Lattouf JB, Grubb RL 3rd, Lee SJ, et al. Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int 2007;99(5):1041-1046.
58. Hata N, Jinzaki M, Kacher D, et al. MR imaging-guided prostate biopsy with surgical navigation software: device validation and feasibility. Radiology 2001;220(1):263-268.
59. Anastasiadis AG, Lichy MP, Nagele U, et al. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies. Eur Urol 2006;50(4):738-748; discussion 748-749.
60. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz M. MR imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 2005;234(2):576-581.
61. Susil RC, Ménard C, Krieger A, et al. Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner. J Urol 2006;175(1):113-120.
62. Singh AK, Krieger A, Lattouf JB, et al. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int 2008;101(2):181-185.
63. Yakar D, Hambrock T, Huisman H, et al. Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy. Invest Radiol 2010;45(3):121-125.
64. Kaplan I, Oldenburg NE, Meskell P, Blake M, Church P, Holupka EJ. Real time MRI-ultrasound image guided stereotactic prostate biopsy. Magn Reson Imaging 2002;20(3):295-299.
65. Reynier C, Troccaz J, Fourneret P, et al. MRI/TRUS data fusion for prostate brachytherapy: preliminary results. Med Phys 2004;31(6):1568-1575.
66. Singh AK, Kruecker J, Xu S, et al. Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy. BJU Int 2008;101(7):841-845.
67. Xu S, Kruecker J, Guion P, et al. Closed-loop control in fused MR-TRUS image-guided prostate biopsy. Med Image Comput Comput Assist Interv 2007;10(pt 1):128-135.
68. Xu S, Kruecker J, Turkbey B, et al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 2008;13(5):255-264.
69. Baumann M, Mozer P, Daanen V, Troccaz J. Prostate biopsy assistance system with gland deformation estimation for enhanced precision. Med Image Comput Comput Assist Interv 2009;12(pt 1):67-74.
70. Martin S, Troccaz J, Daanenc V. Automated segmentation of the prostate in 3D MR images using a probabilistic atlas and a spatially constrained deformable model. Med Phys 2010;37(4):1579-1590.
71. Natarajan S, Marks LS, Margolis DJ, et al. Clinical application of a 3D ultrasound-guided prostate biopsy system. Urol Oncol 2011;29(3):334-342.
72. Chinzei K, Hata N, Jolesz FA, Kikinis R. MR compatible surgical assist robot: system integration and preliminary feasibility study. In: Delp S, DiGioia A, Jaramaz B, eds. Medical Image Computing and Computer-Assisted Intervention: MICCAI 2000. Lecture Notes in Computer Science, Vol 1935. Berlin, Germany: Springer, 2000; 921-930.
73. Krieger A, Susil RC, Ménard C, et al. Design of a novel MRI compatible manipulator for image guided prostate interventions. IEEE Trans Biomed Eng 2005;52(2):306-313.
74. Xu H, Lasso A, Vikal S, et al. MRI-guided robotic prostate biopsy: a clinical accuracy validation. Med Image Comput Comput Assist Interv 2010;13(pt 3):383-391.
75. Stoianovici D, Patriciu A, Petrisor D, Mazilu D, Kavoussi L. A new type of motor: pneumatic step motor. IEEE/ASME Trans Mechatron 2007;12(1): 98-106.
76. Elhawary H, Zivanovic A, Rea M, et al. A MR compatible mechatronic system to facilitate magic angle experiments in vivo. Med Image Comput Comput Assist Interv 2007;10(pt 2):604-611.
77. Suzuki T, Liao H, Kobayashi E, Sakuma I. Ultrasonic motor driving method for EMI-free image in MR image-guided surgical robotic system. In: IROS 2007: IEEE/RSJ International Conference on Intelligent Robots and Systems-2007 [online conference proceedings]; 522-527.
78. Taillant E, Avila-Vilchis J, Allegrini C, Bricault I, Cinquin P. CT and MR compatible light puncture robot: architectural design and first experiments. In: Barillot C, Haynor DR, Hellier P, eds. Medical Image Computing and Computer-Assisted Intervention: MICCAI 2004. Lecture Notes in Computer Science, Vol 3217. Berlin, Germany: Springer, 2004; 145-152.
79. Melzer A, Gutmann B, Remmele T, et al. INNOMOTION for percutaneous image-guided interventions: principles and evaluation of this MR-and CT-compatible robotic system. IEEE Eng Med Biol Mag 2008;27(3):66-73.
80. Gassert R, Moser R, Burdet E, Bleuler H. MRI/ fMRI-compatible robotic system with force feedback for interaction with human motion. IEEE/ ASME Trans Mechatron 2006;11(2):216-224.
81. Stoianovici D, Song D, Petrisor D, et al. "MRI Stealth" robot for prostate interventions. Minim Invasive Ther Allied Technol 2007;16(4):241-248.
82. Zangos S, Herzog C, Eichler K, et al. MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland. Eur Radiol 2007;17(4): 1118-1124.
83. Zangos S, Melzer A, Eichler K, et al. MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions. Radiology 2011;259(3): 903-910.